From: Seroprevalence of HIV, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the netherlands
Number in methadone care
HCV screening
N (%)
HCV prevalence
Amsterdam*
2566
1359 (53%)
350 (26%)
- starting treatment1
53 (15%)
Heerlen**
287
190 (66%)
115 (61%)
- starting treatment
55 (48%)